改善瘤诊断儿科患者功能性的干预措施:系统性审查和元分析协议
Kellyane Munick Holanda1,2, Jamile Vivas Costa3, Wallingson Michael Gonçalves Pereira4
1Facultade de Fisioterapia, Universidade da Coruna, A Coruña, Spain kellyanemunick@gmail.com.
BMJ open
|February 26, 2026
概括
本系统性审查评估了儿童癌症患者的基于功能性的干预措施. 它旨在总结关于改善该人口的功能结果和生活质量的证据.
科学领域:
- 儿科瘤学 儿科瘤学
- 康复医学 康复医学 康复医学
- 系统审查方法论 系统审查方法论
背景情况:
- 癌症是全球儿童和青少年死亡和发病的主要原因.
- 基于功能性的干预措施对于儿科癌症患者至关重要.
- 需要对这些干预措施的证据进行全面的总结.
研究的目的:
- 系统地审查和总结有关儿童癌症患者功能性干预措施有效性的证据.
- 评估这些干预措施对功能指标和与健康相关的生活质量的影响.
- 发现研究缺口,并为临床实践提供信息.
主要方法:
- 按照PRISMA 2020和Cochrane手册的指导方针进行系统审查.
- 在多个数据库 (PubMed,Embase,Web of Science等) 中进行搜索. 试验和试验注册册表.
- 包括随机对照试验,评估儿童癌症患者的基于功能性的干预措施.
- 使用Cochrane偏差风险工具进行偏差风险评估 2.
- 使用R统计软件进行叙事综合和元分析 (如果可能的话).
- 使用推评估,开发和评估 (GRADE) 的评级来评估证据的确定性.
主要成果:
- 当审查完成并可获得结果后,该部分将被填写.
结论:
- 当审查完成并得出结论后,该部分将被填写.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
289
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Cancer Survival Analysis
805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
3.6K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
3.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
384
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
384

